Thomas Kipps
Professor of Medicine · University of California (San Diego) Medical Center
Credentials: · · · · ·
History
- 1982–1983
Hematology
- 1979–1982
Internal Medicine
- 1975–1979
Research
Proceedings of the National Academy of Sciences of the United States of America · 2002 · 3,960 citations
miR-15 and miR-16 induce apoptosis by targeting BCL2
Proceedings of the National Academy of Sciences of the United States of America · 2005 · 2,870 citations
Blood · 2008 · 2,588 citations
61 papers · 9 as a fellow
- JB
51 papers
- DC
49 papers
46 papers
41 papers · 10 as a fellow
- SO
36 papers
- MK
30 papers
- KR
29 papers
Grants
- 1996–2031
Specialized Cancer Center Support Grant
National Cancer Institute · P30
Project lead · $4.5M · University of California, San Diego
- 2019–2025
Non-Canonical Wnt-Receptor Signaling and Targeted Therapies
National Cancer Institute · R01
Contact PI · $3.2M · University of California, San Diego
- 1999–2018
Chronic Lymphocytic Leukemia Research Consortium
National Cancer Institute · P01
Contact PI · $59.5M · University of California, San Diego
- 1989–2015
Antibody V Gene Expression B Cell Lymphocytic Leukemia
National Cancer Institute · R37
Contact PI · $5.7M · University of California, San Diego
Clinical trials
- 2017–2022
Principal investigator · Completed · Phase 1
University of California, San Diego
- 2015–2022
Principal investigator · Completed · Phase 1, Phase 2
University of California, San Diego
- 2011–2014
Sorafenib for the Treatment of Chronic Lymphocytic Leukemia (CLL)
Principal investigator · Terminated · Phase 2
Thomas Kipps
- 2011–2014
Revlimid® as Consolidation Treatment Chronic Lymphocytic Leukemia
Principal investigator · Terminated · Phase 2
Thomas Kipps